AAVogen
Company Details
Status: Private
Employees: 1-10
Location:
Rockville, Maryland, United States of America
Type:
sample
Technology:
sample
sample
sample
sample
sample
sample
About: Our mission is to make you stronger. The company was founded by a family directly impacted by three muscle wasting diseases: Duchenne muscular dystrophy, cancer cachexia and COPD. Our fight is personal and our commitment to developing better and more effective therapies is undaunted.
AVGN7 prevents muscle wasting in different animal models and can restore muscle mass and strength even after wasting has already occurred. It works when injected directly into muscle or when administered systemically to all muscles. It was also designed to avoid the potentially serious side-effects of other "myostatin attenuating" therapies.
AVGN7 for the durable maintenance of muscle mass and function.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
AAVogen | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.